COVID-19 outcomes in HIV patients: A review

Area of Science:

• Public Health
• Infectious Diseases
• Immunology

Background:

• COVID-19 significantly increases risks for individuals with underlying conditions like diabetes and Human Immunodeficiency Virus (HIV).
• People living with HIV (PLHIV) are particularly vulnerable to severe COVID-19 outcomes, especially in resource-limited settings.
• Pandemic-related disruptions, including lockdowns, hinder access to critical healthcare for PLHIV.

Purpose of the Study:

• To examine the multifaceted impact of the COVID-19 pandemic on individuals living with HIV.
• To identify similarities and differences in COVID-19's effects on PLHIV compared to other high-risk groups.
• To highlight the urgent need for healthcare systems to address the unique challenges faced by PLHIV during the pandemic.

Main Methods:

• Literature review and synthesis of emerging evidence on COVID-19 and HIV.
• Analysis of pandemic-related impacts on healthcare access and mental health outcomes for PLHIV.
• Comparative assessment of risks and challenges for immunocompromised individuals.

Main Results:

• COVID-19 exacerbates mental health conditions like depression and anxiety in PLHIV.
• Fear of COVID-19 and pandemic-related stigma compound existing challenges for PLHIV.
• Disruptions to HIV care during lockdowns pose significant risks to PLHIV's health.
• PLHIV face increased vulnerability to severe COVID-19 due to compromised immune status.

Conclusions:

• The COVID-19 pandemic presents a dual threat to PLHIV, impacting both physical and mental health.
• Enhanced, tailored healthcare interventions are crucial for PLHIV during public health crises.
• Healthcare centers must prioritize support for immunocompromised populations, including PLHIV, to mitigate adverse outcomes.